Funding
Who raised, when, and from whom? Explore announced rounds, including emerging Indian companies, and company-reported SEC notices. Each amount keeps its original source and date.
363 filings · Form D notices of private raises, 2024-01-02 to 2026-03-31
QurAlis CorpPharmaceuticals
Cambridge, Massachusetts · Debt, Options, Convertible Promissory Notes · 19 investors · Laia Crespo-Martin, Shafique Virani
TNF Pharmaceuticals, Inc.Pharmaceuticals
New York, New York · founded 2023 · Equity, Options, Convertible · 12 investors · Christopher Schreiber, Bruce Bernstein
Incyclix Bio, LLCPharmaceuticals
Durham, North Carolina · Equity · 4 investors · Norman Sharpless, Fredric Eshelman
Illudent, Inc.Pharmaceuticals
San Diego, California · Equity · 11 investors · Michael Kelner, Joe Gatto
Corner Therapeutics, Inc.Pharmaceuticals
Watertown, Massachusetts · Equity · 14 investors · Andrew Bellinger, Nichols Garrett
PLEOPHARMA, INC.Pharmaceuticals
Phoenixville, Pennsylvania · Equity · 9 investors · Jay Constantine, Thomas Poche
Invirsa, Inc.Pharmaceuticals
Columbus, Ohio · Equity, Debt, Options, Convertible · 14 investors · Rachael Wingo, Wayne Embree
Invirsa, Inc.Pharmaceuticals
Columbus, Ohio · Equity, Debt, Options, Convertible · 14 investors · Robert Shalwitz, Rachael Wingo
Coeptis Therapeutics Holdings, Inc.Pharmaceuticals
Wexford, Pennsylvania · founded 2022 · Equity · 9 investors · Christopher Cochran, David Mehalick
Scienture Holdings, Inc.Pharmaceuticals
Commack, New York · Equity · 8 investors · Donald Fell, Subbarao Jayanthi
Scienture Holdings, Inc.Pharmaceuticals
Commack, New York · Equity · 4 investors · Shankar Hariharan, Mayur Doshi
D&D Pharmatech Inc.Pharmaceuticals
Seongnam-Si, Korea, Republic Of · Debt, Convertible, Convertible Bonds · 8 investors · Seulki Lee, Sungmook Lim
EIKONOKLASTES THERAPEUTICS, INC.Pharmaceuticals
Cincinnati, Ohio · Equity · 14 investors · Thomas Finn, Joseph Nolan
Artax Biopharma, Inc.Pharmaceuticals
Cambridge, Massachusetts · Debt, Options · 30 investors · Damia Tormo, Ph.D., Alan Walts
Adora Animal Health CorpPharmaceuticals
Franklin, Tennessee · Equity · 1 investors · Thomas Vaughn, Thomas D'Ambra
HYPERION DEFI, INC.Pharmaceuticals
Laguna Hills, California · Equity, Options · 5 investors · Michael Geltzeiler, Michael Rowe
Plexiform Bioscience Inc.Pharmaceuticals
Dover, Delaware · founded 2024 · Equity · 14 investors · Saad Ahmad
Plexiform Bioscience Inc.Pharmaceuticals
Dover, Delaware · founded 2024 · Equity · 14 investors · Saad Ahmad
Renibus Therapeutics, Inc.Pharmaceuticals
Southlake, Texas · Equity, Options, Convertible · 59 investors · Jamie Donadio, Bhupinder Singh
Sensorium Therapeutics, Inc.Pharmaceuticals
Boston, Massachusetts · founded 2021 · Equity, Options · 19 investors · Jerrold Rosenbaum, Ryan Katz
Decoy Therapeutics, Inc.Pharmaceuticals
Cambridge, Massachusetts · Debt, Convertible · 20 investors · Barbara Hibner, Frederick Pierce
Biofrontera Inc.Pharmaceuticals
Woburn, Massachusetts · Equity, Series C Convertible Preferred Stock · 5 investors · Beth Hoffman, John Borer III
Pelthos Therapeutics Inc.Pharmaceuticals
Durham, North Carolina · founded 2021 · Equity, Options, Convertible, Series A Convertible Preferred Stock, par value $0 · 13 investors · Matthew Pauls, Richard Malamut
NLS Pharmaceutics Ltd.Pharmaceuticals
Zurich, Switzerland · Equity, Options, Convertible · 3 investors · Gian-Marco Rinaldi de la Cruz, Olivier Samuel
Inventure, LLCPharmaceuticals
Southbury, Connecticut · Equity · 6 investors · Kyle Salem, Brad Rummer
Aevum Longevity Corp.Pharmaceuticals
Vancouver, British Columbia, Canada · founded 2023 · Equity · 4 investors · Amandeep Gill, Robert Payment
Paragon Biosciences Emalex Capital, Inc.Pharmaceuticals
Chicaco, Illinois · Equity · 42 investors · Patrick Morris, Jeffrey Aronin
Insigna, Inc.Pharmaceuticals
Champaign, Illinois · Equity · 2 investors · Byron Wittenberg, CheMyong Ko
ACTUATE THERAPEUTICS, INC.Pharmaceuticals
Fort Worth, Texas · Equity, Options · 8 investors · Todd Thomson, Daniel Schmitt
General Oncology, Inc.Pharmaceuticals
Brookline, Massachusetts · Equity, Options · 43 investors · Michael Petit, Arnold Glazier